Heavy smokers screened for lung cancer face more than triple the two-year risk of vertebral fractures if their scans show osteoporotic bone density, according to research published October 27 in Radiology. The findings demonstrate that automated analysis of routine chest scans can flag compromised skeletal health.
In Plain English: The Clinical Takeaway
- Opportunistic screening: Low-dose CT scans performed to check for lung cancer can simultaneously evaluate bone mineral density using automated software.
- Stratified risk: Patients with osteoporotic bone density on these scans showed a 5.9% incidence of vertebral fractures within two years, compared to 0.9% for those with normal bone density.
- Actionable thresholds: The observed fracture rate in this heavy-smoking cohort exceeds the threshold at which current guidelines recommend antiosteoporotic drug therapy.
Automated Volumetric Density Analysis Identifies High-Risk Spines
Researchers at University Medical Center Freiburg in Germany evaluated data from 21,856 participants in the U.S.-based National Lung Screening Trial. The cohort consisted of heavy smokers aged 55 to 74 years with at least 30 pack-years of smoking history. The investigators applied SpineQ software version 1.0 from Bonescreen to existing low-dose computed tomography (LDCT) lung cancer screening scans.
The software automatically classified thoracic and lumbar volumetric bone mineral density (vBMD) into three categories: normal density (≥ 120 mg/cm³), low bone mass (80 to ≤ 120 mg/cm³), or osteoporotic (< 80 mg/cm³). Among 18,211 participants with two-year follow-up imaging, the incidence of new vertebral fractures rose alongside declining bone density. Patients with low bone mass experienced a two-year fracture rate of 2.0% with an adjusted relative risk of 2.07. Those classified with osteoporotic vBMD faced a 5.9% fracture incidence, yielding an adjusted relative risk of 3.40 compared to the normal-density group.
| Bone Density Status | vBMD Threshold | 2-Year Fracture Incidence | Adjusted Relative Risk |
|---|---|---|---|
| Normal | ≥ 120 mg/cm³ | 0.9% | 1.0 (Reference) |
| Low Bone Mass | 80 to ≤ 120 mg/cm³ | 2.0% | 2.07 |
| Osteoporotic | < 80 mg/cm³ | 5.9% | 3.40 |
Lead author Maximilian Löffler, MD, and his colleagues pointed out that risk factors for cancer and osteoporosis, such as smoking and advanced age, overlap. Additional analyses revealed that osteoporotic vBMD correlated with overall mortality among male participants (adjusted hazard ratio, 1.24), though no such correlation appeared in women following comprehensive risk adjustment.
Implementation Challenges in Existing Chest CT Workflows
Antiosteoporotic drug therapy is currently recommended by guidelines when fracture rates surpass the 5.9% incidence observed over two years among heavy smokers with osteoporosis. Because LDCT is increasingly implemented for heavy smokers worldwide, embedding automated bone assessment into existing radiology pipelines could be valuable.
In an accompanying editorial published via Radiology, Miriam Bredella, MD, of NYU Langone Health and NYU Grossman School of Medicine, wrote that the principal challenge is now implementation rather than measurement. Commenting further, Bredella emphasized that the crucial upcoming milestone is a pragmatic implementation trial designed to automatically flag high-risk patients, channel findings into a structured management track, assess whether this pathway enhances proper osteoporosis assessment and care, and ultimately decrease fracture rates without triggering excessive diagnostic testing or overtreatment.
The investigators concluded that subsequent research must determine whether incorporating automated bone density evaluation into LDCT clinical pipelines successfully prevents fractures and possibly lowers mortality rates.
References
- Opportunistic Osteoporosis Screening at Low-Dose CT Lung Cancer Screening. Radiology.
- Bredella, M. (2026). Radiology.
Disclaimer: This article is intended for informational and educational purposes only and does not substitute for professional medical advice, diagnosis, or treatment.
